Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 36.18

-4.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	11/1/2004 12:33:34 AM
	Read Replies (1) of 566

Rigel Rated New `Buy' at Hibernia Southcoast :RIGL US 2004-10-27 08:33 (New York) Princeton, New Jersey, Oct. 27 (Bloomberg Data) -- Rigel Pharmaceuticals Inc. (RIGL US) was rated new ``buy'' in new coverage by analyst Bennett C Weintraub at Hibernia Southcoast Capital Inc. The price target is $38.00 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next